BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 3514684)

  • 41. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999).
    Walton RM; Hendrick MJ
    Vet Pathol; 2001 Sep; 38(5):504-11. PubMed ID: 11572557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant lymphoma, unclassified, most consistent with Hodgkin's disease, lymphocyte depleted type, reticular.
    Patterson SD
    Ultrastruct Pathol; 1985; 9(3-4):233-9. PubMed ID: 3911529
    [No Abstract]   [Full Text] [Related]  

  • 43. Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils.
    Childs CC; Parham DM; Berard CW
    Am J Surg Pathol; 1987 Feb; 11(2):122-32. PubMed ID: 3812872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.
    Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD
    Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cells of the phenotype HNK-1 + (CD 57 +) in reactive adenopathies, lymphomas and Hodgkin's disease].
    Merlio JP; Caveriviere P; al Saati T; Coindre JM; de Mascarel A; Delsol G
    Ann Pathol; 1990; 10(3):166-73. PubMed ID: 1696823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous expression of activated lymphoid cell-associated and granulocytic cell-associated antigens on Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
    Abe M; Wachi E; Wakasa H
    Pathol Res Pract; 1988 Aug; 183(4):418-24. PubMed ID: 3186542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers.
    Burns BF; Colby TV; Dorfman RF
    Am J Surg Pathol; 1984 Apr; 8(4):253-61. PubMed ID: 6369997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 49. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy.
    Staples WG; Gétaz EP
    S Afr Med J; 1977 Jul; 52(2):60-3. PubMed ID: 578338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of LeuM1 monoclonal antibody for the diagnosis of Hodgkin's disease.
    Memon GM; Alam SM
    J Pak Med Assoc; 1990 Jul; 40(7):156-9. PubMed ID: 1980316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ammoniacal silver staining of lymph node cells. II. Reactive follicular hyperplasia and its relationship with Hodgkin's disease.
    Rengifo E; Quintero S; Marinello Z
    Neoplasma; 1985; 32(6):741-4. PubMed ID: 2418374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Lewis X antigen. A new paraffin section marker for Reed-Sternberg cells.
    Ree HJ; Teplitz C; Khan A
    Cancer; 1991 Mar; 67(5):1338-46. PubMed ID: 1703918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and expression of CT45 in Hodgkin's lymphoma.
    Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
    Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of K-1 (CD-30) marker in Hodgkin's disease.
    Shakoor KA; Saleh A; Khanzada MS
    J Pak Med Assoc; 2002 Oct; 52(10):442-7. PubMed ID: 12553671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature.
    Hall PA; D'Ardenne AJ
    J Clin Pathol; 1987 Nov; 40(11):1298-304. PubMed ID: 3320093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
    Basu D; Roy SK
    Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The significance of mummy cell in the diagnosis of Hodgkin's disease].
    Yan CH
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):143-5. PubMed ID: 2582554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution.
    Chittal SM; Alard C; Rossi JF; al Saati T; Le Tourneau A; Diebold J; Delsol G
    Am J Surg Pathol; 1990 Nov; 14(11):1024-35. PubMed ID: 2240355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.